Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation

Christelle Piperoglou (1) , Guillaume Larid (1) , Blandine Vallentin (1) , Laura Balligand (1) , Adeline Crinier (2) , Nathalie Banzet (1) , Catherine Farnarier (1) , Elena Gomez‐massa (2) , Aranzazu Cruz Adalia (2) , Gérard Michel (1) , Claire Galambrun (1) , Vincent Barlogis (1) , Eric Vivier (1, 2, 3) , Frédéric Vély (1, 2)

1 TIMONE - Hôpital de la Timone [CHU - APHM]
2 CIML - Centre d'Immunologie de Marseille - Luminy
3 Innate Pharma

Lymphocytes are essential for microbial immunity, tumor surveillance, and tissue homeostasis. However, the in vivo development and function of helper-like innate lymphoid cells (ILCs) in humans remain much less well understood than those of T, B, and NK cells. We monitored hematopoietic stem cell transplantation (HSCT) to determine the kinetics of ILC development in both children and adults. It was found that, unlike NK cells, helper-like ILCs recovered slowly, mirroring the pattern observed for T cells, with normalization achieved at 1 year. The type of graft and the proportion of CD34+ cells in the graft did not significantly affect ILC reconstitution. As HSCT is often complicated by acute or chronic graft-versus-host disease (GVHD), the potential role of ILC subsets in maintaining tissue integrity in these conditions was also analyzed. It was found that GVHD was associated with lower levels of activated and gut-homing NKp44+ ILCP, consistent with a non-redundant role of this ILC subset in preventing this life-threatening disorder in lymphopenic conditions.

Domains: Life Sciences [q-bio]

Christelle Piperoglou, Guillaume Larid, Blandine Vallentin, Laura Balligand, Adeline Crinier, et al.. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Journal of Leukocyte Biology, 2021, ⟨10.1002/JLB.5A1019-522RR⟩. ⟨hal-03375093⟩